See more : Modison Metals Limited (MODISNME.NS) Income Statement Analysis – Financial Results
Complete financial analysis of California Resources Corporation (CRC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of California Resources Corporation, a leading company in the Oil & Gas Exploration & Production industry within the Energy sector.
You may be interested
- NTN Corporation (6472.T) Income Statement Analysis – Financial Results
- Quanergy Systems, Inc. (QNGY) Income Statement Analysis – Financial Results
- Immunome, Inc. (IMNM) Income Statement Analysis – Financial Results
- Aktiebolaget Fastator (publ) (FASTAT.ST) Income Statement Analysis – Financial Results
- SK Discovery Co., Ltd. (006120.KS) Income Statement Analysis – Financial Results
California Resources Corporation (CRC)
About California Resources Corporation
California Resources Corporation operates as an independent oil and natural gas company. The company explores for, produces, gathers, processes, and markets crude oil, natural gas, and natural gas liquids for marketers, California refineries, and other purchasers that have access to transportation and storage facilities. As of December 31, 2021, it had interests in approximately 1.9 million net mineral acres with proved reserves totaled an estimated 480 million barrels of oil equivalent. The company also engages in the generation and sale of electricity to the local utility and the grid. The company was incorporated in 2014 and is based in Santa Clarita, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.81B | 3.26B | 2.57B | 1.61B | 2.69B | 3.06B | 2.10B | 1.75B | 2.40B | 4.17B | 4.29B | 4.07B | 3.94B |
| Cost of Revenue | 1.41B | 1.47B | 1.29B | 1.30B | 1.46B | 1.41B | 1.42B | 1.36B | 1.96B | 2.22B | 2.21B | 2.15B | 1.75B |
| Gross Profit | 1.41B | 1.79B | 1.28B | 308.00M | 1.23B | 1.65B | 676.00M | 394.00M | 448.00M | 1.95B | 2.08B | 1.93B | 2.19B |
| Gross Profit Ratio | 49.95% | 54.79% | 49.71% | 19.14% | 45.79% | 53.84% | 32.25% | 22.48% | 18.64% | 46.78% | 48.42% | 47.34% | 55.59% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 267.00M | 222.00M | 200.00M | 252.00M | 290.00M | 299.00M | 259.00M | 248.00M | 354.00M | 336.00M | 326.00M | 273.00M | 287.00M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 267.00M | 222.00M | 200.00M | 252.00M | 290.00M | 299.00M | 259.00M | 248.00M | 354.00M | 336.00M | 326.00M | 273.00M | 287.00M |
| Other Expenses | 330.00M | 257.00M | 202.00M | 155.00M | 455.00M | -23.00M | -7.00M | 30.00M | 392.00M | 563.00M | 302.00M | 445.00M | 261.00M |
| Operating Expenses | 597.00M | 479.00M | 402.00M | 407.00M | 745.00M | 881.00M | 523.00M | 494.00M | 746.00M | 899.00M | 628.00M | 718.00M | 548.00M |
| Cost & Expenses | 2.01B | 1.95B | 1.69B | 1.71B | 2.21B | 2.30B | 1.94B | 1.85B | 2.70B | 3.12B | 2.84B | 2.86B | 2.30B |
| Interest Income | 0.00 | 53.00M | 54.00M | 217.00M | 383.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 56.00M | 53.00M | 54.00M | 217.00M | 383.00M | 379.00M | 343.00M | 328.00M | 326.00M | 72.00M | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 225.00M | 241.00M | 263.00M | 362.00M | 514.00M | 545.00M | 571.00M | 562.00M | 1.00B | 1.20B | 1.14B | 926.00M | 675.00M |
| EBITDA | 1.08B | 1.31B | 871.00M | 2.45B | 997.00M | 1.35B | 652.00M | 1.08B | -4.14B | -1.05B | 2.73B | 2.14B | 2.39B |
| EBITDA Ratio | 38.22% | 40.15% | 33.96% | -11.68% | 15.45% | 24.32% | 32.92% | 27.90% | 231.29% | 135.47% | 60.47% | 53.15% | 58.81% |
| Operating Income | 808.00M | 1.11B | 658.00M | -1.89B | -55.00M | 769.00M | 63.00M | -306.00M | -122.00M | -2.35B | 1.45B | 1.18B | 1.64B |
| Operating Income Ratio | 28.72% | 34.07% | 25.65% | -117.15% | -2.04% | 25.11% | 3.01% | -17.46% | -5.08% | -56.29% | 33.77% | 29.00% | 41.67% |
| Total Other Income/Expenses | -60.00M | -51.00M | -64.00M | 2.02B | -329.00M | -107.00M | -403.00M | 494.00M | -5.35B | -3.40B | -140.00M | -41.00M | 0.00 |
| Income Before Tax | 748.00M | 761.00M | 229.00M | 1.87B | 100.00M | 429.00M | -262.00M | 201.00M | -5.48B | -2.42B | 1.45B | 1.18B | 1.64B |
| Income Before Tax Ratio | 26.59% | 23.36% | 8.93% | 116.28% | 3.71% | 14.01% | -12.50% | 11.47% | -227.88% | -58.02% | 33.77% | 29.00% | 41.67% |
| Income Tax Expense | 184.00M | 237.00M | -396.00M | -1.46B | 1.00M | 101.00M | 340.00M | -78.00M | -1.92B | -987.00M | 578.00M | 482.00M | 670.00M |
| Net Income | 564.00M | 524.00M | 612.00M | 3.34B | 99.00M | 328.00M | -266.00M | 279.00M | -3.55B | -1.43B | 869.00M | 699.00M | 971.00M |
| Net Income Ratio | 20.05% | 16.08% | 23.86% | 207.27% | 3.68% | 10.71% | -12.69% | 15.92% | -147.90% | -34.36% | 20.28% | 17.16% | 24.66% |
| EPS | 8.10 | 6.94 | 7.46 | 40.03 | 2.02 | 6.92 | -6.26 | 6.76 | -92.79 | -37.54 | 17.31 | 13.93 | 2.51 |
| EPS Diluted | 7.78 | 6.75 | 7.37 | 40.03 | 2.02 | 6.92 | -6.26 | 6.76 | -92.79 | -37.54 | 17.31 | 13.93 | 2.51 |
| Weighted Avg Shares Out | 69.60M | 75.50M | 82.00M | 83.32M | 49.00M | 47.40M | 42.49M | 40.40M | 38.30M | 38.20M | 49.40M | 49.40M | 387.00M |
| Weighted Avg Shares Out (Dil) | 72.50M | 77.60M | 83.00M | 83.32M | 49.00M | 47.40M | 42.50M | 40.40M | 38.30M | 38.20M | 49.40M | 49.40M | 387.00M |
California Resources Corporation Announces Pricing of Upsized Private Offering of $300 Million of Additional 8.250% Senior Unsecured Notes due 2029
LONG BEACH, Calif.--(BUSINESS WIRE)--California Resources Corporation (NYSE: CRC) (the “Company”) announced today the pricing of an upsized private offering of $300 million in aggregate principal amount of its 8.250% senior unsecured notes due 2029 (the “Notes”). The offering size was...
California Resources Corporation (CRC) Q2 2024 Earnings Call Transcript
California Resources Corporation (NYSE:CRC ) Q2 2024 Earnings Conference Call August 7, 2024 1:00 PM ET Company Participants Joanna Park - Vice President, Investor Relations & Treasurer Francisco Leon - Chief Executive Officer Nelly Molina - Chief Financial Officer Jay...
New Strong Sell Stocks for August 7th
IPGP, CRC and CUYTY have been added to the Zacks Rank #5 (Strong Sell) List on August 7, 2024.
California Resources Corporation (CRC) Misses Q2 Earnings and Revenue Estimates
California Resources Corporation (CRC) came out with quarterly earnings of $0.60 per share, missing the Zacks Consensus Estimate of $0.96 per share. This compares to earnings of $0.53 per share a year ago.
California Resources Reports Second Quarter 2024 Financial and Operating Results
LONG BEACH, Calif.--(BUSINESS WIRE)-- #CCS--California Resources Corporation (NYSE: CRC) today reported financial and operating results for the second quarter of 2024. The Company plans to host a conference call and webcast at 1 p.m. ET (10 a.m. PT) on Wednesday,...
Carbon TerraVault Provides Second Quarter 2024 Update
LONG BEACH, Calif.--(BUSINESS WIRE)-- #CCS--Carbon TerraVault Holdings, LLC (CTV) today provided a second quarter 2024 update. California Resources Corporation (NYSE: CRC) conducts its carbon management business through CTV and its subsidiaries, which pursues carbon capture and sequestration (CCS) projects that...
New Strong Sell Stocks for July 25th
ALGT, CRC and MP have been added to the Zacks Rank #5 (Strong Sell) List on July 25, 2024.
Exact Sciences Awards Grants to 28 Organizations Focused on Increasing Colorectal Cancer Screening
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences, a leading provider of cancer screening and diagnostic tests, announced today that it awarded a total of $1.5 million to 28 organizations through its Funding Opportunities for CRC Screening Uptake Strategies (FOCUS) Program. Grant recipients are...
Mainz Biomed Announces Submission for FDA Breakthrough Device Designation for its Next Generation CRC Screening Test
On the basis of its positive clinical studies Mainz Biomed has now defined the final configuration including its novel mRNA biomarkers of the Next Generation Test to be used in pivotal registration study ReconAAsense A recent clinical analysis of this...
California Resources Corporation Schedules Second Quarter 2024 Earnings Conference Call
LONG BEACH, Calif.--(BUSINESS WIRE)-- #2Q24Results--California Resources Corporation (NYSE: CRC) plans to release its second quarter 2024 financial results on Tuesday, August 6th after market close. The Company will hold a conference call to discuss these financial results on Wednesday, August...
Source: https://incomestatements.info
Category: Stock Reports